Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de Madrid  >  FAES Farma SA    FAE   ES0134950F36

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Madrid
04/18/2017 04/19/2017 04/20/2017 04/21/2017 04/24/2017 Date
3.3(c) 3.265(c) 3.255(c) 3.225(c) 3.22 Last
305 043 226 142 261 169 155 064 321 738 Volume
0.00% -1.06% -0.31% -0.92% -0.16% Change
More quotes
Financials (€)
Sales 2017 252 M
EBIT 2017 57,6 M
Net income 2017 -
Finance 2017 78,4 M
Yield 2017 2,46%
Sales 2018 262 M
EBIT 2018 62,6 M
Net income 2018 41,0 M
Finance 2018 101 M
Yield 2018 2,88%
P/E ratio 2017 18,84
P/E ratio 2018 17,79
EV / Sales2017 3,04x
EV / Sales2018 2,84x
Capitalization 843 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
05/17Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
2016 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA SA : ex-dividend day for final dividend
2015 FAES FARMA : Statement 05/18/2015 (39 k.). Faes Farma has licensed a pharmaceuti..
2015 FAES FARMA : Comunicado 05/01/2015 (59 k.). Dividendo flexible. Datos de cierre ..
2015 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
More news
Sector news : Pharmaceuticals - NEC
03:01a Becton Dickinson to acquire Bard for $24 billion
04/22DJNOVARTIS : Tests New Alzheimer's Drug on People Who Don't Have the Disease
04/21DJFDA OKs Samsung Bioepis's biosimilar version of J&J's Remicade
04/21 Teva's new asthma inhaler poses first competition for GSK's Advair
04/19DJSHIRE : Files 8K - Other Events
More sector news : Pharmaceuticals - NEC
Latest Tweets
2015#Spain: Faes Farma : #Market Analysts predicted Oct 2015 sales growth & p.. 
2015#Frankfurt #stocks: Faes Farma : #Merger #Acquisition Analysts say: soft Aug .. 
2015Faes Farma desembarca en China mediante una 'joint venture' con Eddingpharm  
2015BRIEF-Faes Farma reaches license agreement for its product in USA  
2015#Frankfurt #stocks: Faes Farma : #Market Analysts conclude meagre sales profi.. 
More tweets
Qtime:10
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends FAES FARMA SA
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 3,25 €
Spread / Average Target 0,71%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gonzalo López Casanueva Co-Managing Director
Francisco Quintanilla Guerra Co-Managing Director
Mariano Ucar Angulo Chairman
Valentín Ruiz Unamunzaga Deputy MD & Director-Corporate Finance
Isidro Hermo Blanco Manager-Pharmaceutical Technology
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FAES FARMA SA-4.02%905
JOHNSON & JOHNSON5.69%330 078
ROCHE HOLDING LTD.8.21%217 624
PFIZER INC.3.57%200 330
NOVARTIS AG-1.08%192 857
MERCK & CO., INC.5.13%169 673
More Results